• Medientyp: E-Artikel
  • Titel: Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004
  • Beteiligte: Lockhart, Shawn R.; Abramson, Murray A.; Beekmann, Susan E.; Gallagher, Gale; Riedel, Stefan; Diekema, Daniel J.; Quinn, John P.; Doern, Gary V.
  • Erschienen: American Society for Microbiology, 2007
  • Erschienen in: Journal of Clinical Microbiology
  • Sprache: Englisch
  • DOI: 10.1128/jcm.01284-07
  • ISSN: 0095-1137; 1098-660X
  • Schlagwörter: Microbiology (medical)
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>ABSTRACT</jats:title> <jats:p> During the 12-year period from 1993 to 2004, antimicrobial susceptibility profiles of 74,394 gram-negative bacillus isolates recovered from intensive care unit (ICU) patients in United States hospitals were determined by participating hospitals and collected in a central location. MICs for 12 different agents were determined using a standardized broth microdilution method. The 11 organisms most frequently isolated were <jats:italic>Pseudomonas aeruginosa</jats:italic> (22.2%), <jats:italic>Escherichia coli</jats:italic> (18.8%), <jats:italic>Klebsiella pneumoniae</jats:italic> (14.2%), <jats:italic>Enterobacter cloacae</jats:italic> (9.1%), <jats:italic>Acinetobacter</jats:italic> spp. (6.2%), <jats:italic>Serratia marcescens</jats:italic> (5.5%), <jats:italic>Enterobacter aerogenes</jats:italic> (4.4%), <jats:italic>Stenotrophomonas maltophilia</jats:italic> (4.3%), <jats:italic>Proteus mirabilis</jats:italic> (4.0%), <jats:italic>Klebsiella oxytoca</jats:italic> (2.7%), and <jats:italic>Citrobacter freundii</jats:italic> (2.0%). Specimen sources included the lower respiratory tract (52.1%), urine (17.3%), and blood (14.2%). Rates of resistance to many of the antibiotics tested remained stable during the 12-year study period. Carbapenems were the most active drugs tested against most of the bacterial species. <jats:italic>E. coli</jats:italic> and <jats:italic>P. mirabilis</jats:italic> remained susceptible to most of the drugs tested. Mean rates of resistance to 9 of the 12 drugs tested increased with <jats:italic>Acinetobacter</jats:italic> spp. Rates of resistance to ciprofloxacin increased over the study period for most species. Ceftazidime was the only agent to which a number of species ( <jats:italic>Acinetobacter</jats:italic> spp., <jats:italic>C. freundii</jats:italic> , <jats:italic>E. aerogenes</jats:italic> , <jats:italic>K. pneumoniae</jats:italic> , <jats:italic>P. aeruginosa</jats:italic> , and <jats:italic>S. marcescens</jats:italic> ) became more susceptible. The prevalence of multidrug resistance, defined as resistance to at least one extended-spectrum cephalosporin, one aminoglycoside, and ciprofloxacin, increased substantially among ICU isolates of <jats:italic>Acinetobacter</jats:italic> spp., <jats:italic>P. aeruginosa</jats:italic> , <jats:italic>K. pneumoniae</jats:italic> , and <jats:italic>E. cloacae</jats:italic> . </jats:p>
  • Zugangsstatus: Freier Zugang